Priya Mahajan

发表

Synthesis of 5-substituted-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one analogs and their biological evaluation as anticancer agents: mTOR inhibitors.

S. Bhushan, R. Vishwakarma, S. Guru, 2014, European journal of medicinal chemistry.

Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.

R. Vishwakarma, Priya Mahajan, A. Nargotra, 2016, ACS combinatorial science.

IDSL.CCDB: a database for exploring inter-chemical correlations in metabolomics and exposomics datasets

D. Barupal, Priya Mahajan, M. Arora, 2022, bioRxiv.

Priya Mahajan, Zahid Anwer, Mohammed Sufiyan, 2022 .

W. Gerwick, Priya Mahajan, E. Ternon, 2022 .

Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5.

R. Vishwakarma, M. Srinivas, Priya Mahajan, 2015, Bioorganic & medicinal chemistry.

Exploring Derivatives of Quinazoline Alkaloid l-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors.

P. R. Sharma, Ashok Kumar, M. Aga, 2017, Journal of medicinal chemistry.

Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.

P. Verma, F. Malik, R. Vishwakarma, 2018, Bioorganic & medicinal chemistry letters.

Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

R. Vishwakarma, G. L. Reddy, Priya Mahajan, 2019, Bioorganic chemistry.

Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-α based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation.

Arunasree M. Kalle, A. Alam, Priya Mahajan, 2013, European journal of medicinal chemistry.

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.

J. P. Sharma, Priya Mahajan, A. Nargotra, 2012, The Journal of antimicrobial chemotherapy.

Fusion of Structure and Ligand Based Methods for Identification of Novel CDK2 Inhibitors

Monika Gupta, Priya Mahajan, A. Nargotra, 2017, J. Chem. Inf. Model..

Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1

F. Malik, Priya Mahajan, A. Nargotra, 2019, Molecular Diversity.

Interplay between cell cycle and autophagy induced by boswellic acid analog

Ashok Kumar, S. Bhushan, B. A. Shah, 2016, Scientific Reports.

Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model.

S. Bhushan, D. Mondhe, F. Malik, 2017, Journal of medicinal chemistry.

Discovery of novel small molecule EGFR inhibitory leads by structure and ligand-based virtual screening

Monika Gupta, Priya Mahajan, A. Nargotra, 2016, Medicinal Chemistry Research.

4-(N-Phenyl-N'-substituted benzenesulfonyl)-6-(4-hydroxyphenyl)quinolines as inhibitors of mammalian target of rapamycin.

F. Malik, R. Vishwakarma, A. Pathania, 2015, Bioorganic & medicinal chemistry.

Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.

Priya Mahajan, A. Nargotra, Shilpa Gupta, 2017, European journal of medicinal chemistry.

Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.

S. Bharate, Priya Mahajan, A. Nargotra, 2019, European journal of pharmacology.

4-(N-Phenyl-N'-substituted benzenesulfonyl)-6-(4-hydroxyphenyl)quinolines as inhibitors of mammalian target of rapamycin.

A. Pathania, Priya Mahajan, Sanghapal D. Sawant, 2015, Bioorganic & medicinal chemistry.